Non-motor symptoms of Parkinson's disease (PD), such as depression, apathy, cognitive impairment, sleep disorders, and sensory symptoms, can have a greater impact on health-related quality of life than motor deficits. In ...
Aug 1, 2018
0
2
(HealthDay)—In adults with type 2 diabetes not adequately controlled with metformin, lixisenatide once daily offers diabetes control similar to that of exenatide twice daily, with some added benefits, according to a study ...
Jun 7, 2013
0
0
A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy. ...
May 6, 2014
0
0
(HealthDay)—The drug Byetta, approved for adults with type 2 diabetes, appears to help severely obese teens lose some weight, a small study found.
Feb 5, 2013
0
0
Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according ...
Feb 4, 2013
0
0
(HealthDay)—For patients with type 2 diabetes, the incidence of major cardiovascular events is similar for those receiving exenatide or placebo, according to a study published online Sept. 14 in the New England Journal ...
Sep 15, 2017
0
0
